Main Session
Sep 29
PQA 07 - Head and Neck Cancer, Lung Cancer/Thoracic Malignancies, and Nursing and Supportive Care

3644 - Radiotherapy Planning for Lung Cancer Using Novel Volumetric Modulated Arc Therapy with Static Angle Modulated Ports and Dynamic Collimator Rotation

03:45pm - 05:00pm ET
Poster Hall - Exhibit Hall A
Screen: 32
POSTER

Presenter(s)

Taro Ueda, MD - Kochi Medical School, Kochi University, Nangoku-shi, Kochi

T. Ueda1, Y. Kondo2, N. Hayashi2, S. Komatsu1, T. Ogura1, T. Fujiwara1, and T. Kimura1; 1Department of Radiation Oncology, Kochi Medical School, Kochi University, Kochi, Japan, 2Department of Medical Technology, Kochi Medical School Hospital, kochi, Japan

Purpose/Objective(s): A newly developed treatment planning technique enables automatic optimization of collimator angles according to target shape and incorporation of static angle modulated ports (STAMPs), which permit beam delivery to stop at arbitrary gantry angles during irradiation (VMATp).This study aimed to compare RAD with conventional volumetric modulated arc therapy (VMAT).

Materials/Methods: Ten patients with unresectable locally advanced lung cancer who underwent definitive radiotherapy at our institution between April 2025 and September 2025, were retrospectively planned with conventional VMAT and VMATp. Radiotherapy was generally performed under Real-time Position Management (RPM)-guided breath-hold at quiet inspiration. Prescription dose was D50% = 66 Gy. Conventional VMAT plan used 2 or 3 static collimator arcs, and VMATp plan used the same number of arcs with dynamic collimator and included 2–4 STAMPs per arc. Dosimetric parameters (including Lung-GTV V5 Gy, V20 Gy, Dmean, PTVD98%, D2%) were compared using the Wilcoxon signed-rank test.

Results: In all ten cases, VMATp reduced lung dose while maintaining dose coverage to the PTV. Compared with conventional VMAT, VMATp showed the following results: Lung-GTV V20 Gy (21.0% vs 18.1%, p= 0.005), V5 Gy (48.3% vs 46.1%, p= 0.075), Dmean (11.7 Gy vs 10.7 Gy, p= 0.005), PTV D98% (85.6% vs 85.6%, p= 0.959), and D2% (105.8% vs 106.2%, p= 0.333).

Conclusion: VMATp enabled lung dose reduction compared with conventional VMAT while maintaining target dose coverage. The use of VMATp in lung cancer improved the quality of radiotherapy treatment planning.

Table1: Comparison of dosimetric parameters between conventional VMAT and VMATp plan

parameter

unit

VMAT

(mean±SD)

VMATp

(mean±SD)

p value

Lung-GTV V5 Gy

%

48.3±10.2

46.1±12.9

0.075

Lung-GTV V20 Gy

%

21.0±7.52

18.1±6.56

0.005

Lung-GTV Dmean

Gy

11.7±3.14

10.7±2.90

0.005

PTV D98%

%

85.6±3.50

85.6±2.53

0.959

PTV D2%

%

105.8±3.59

106.2±3.43

0.333